Tadalafil is an elite, long-acting selective PDE5 inhibitor distinguished by its unique structure and extended 36-hour therapeutic window. It binds with exceptionally high affinity to the catalytic site of the PDE5 enzyme, preserving intracellular cGMP levels across vascular smooth muscle tissues. This sustained molecular action allows for uniform, steady relaxation of the arteries supplying the corpus cavernosum as well as the smooth muscle fibres of the prostate and bladder neck. Because of its prolonged pharmacokinetics, daily low-dose administration provides continuous, dual protection that stabilizes urinary flow mechanics while maintaining spontaneous erectile function.